MADRID (S&P Global Ratings) Nov. 24, 2025--S&P Global Ratings today withdrew its 'BB+' rating on the $1 billion senior secured term loan A, due 2030, that was issued by Danish pharmaceutical company Genmab A/S. The rating was withdrawn at the company's request. The other ratings assigned to Genmab A/S and its debt instruments on Nov. 10, 2025, are unaffected. Criteria Corporates General: Sector-Specific Corporate Methodology , July 7, 2025 Criteria Corporates General: Methodology: Management And Governance Credit Factors For Corporate Entities , Jan. 7, 2024 Criteria Corporates General: Corporate Methodology , Jan. 7, 2024 General Criteria: Environmental, Social, And Governance Principles In Credit Ratings , Oct. 10, 2021 Criteria Corporates General: Corporate Methodology: Ratios And Adjustments
